P409 Non-medical reverse switch between the originator infliximab and its biosimilar in patients with inflammatory bowel disease: clinical outcomes and therapeutic drug monitoring

Subjects

Subjects :

medicine.medical_specialty
medicine.diagnostic_test
business.industry
Gastroenterology
Biosimilar
General Medicine
medicine.disease
Inflammatory bowel disease
Infliximab
Therapeutic drug monitoring
medicine
In patient
business
Intensive care medicine
medicine.drug

Details

ISSN :

18764479 and 18739946

Volume :

13

Database :

OpenAIRE

Journal :

Journal of Crohn's and Colitis

Accession number :

edsair.doi...........21e0de673f6a7bdcf3da7014290ab4cf

Full Text :

https://doi.org/10.1093/ecco-jcc/jjy222.533